Ann: Argenica Successfully Completes $12.0m Placement, page-22

I had to look that up ... lol. No, not cross promoting but pointing out that 19% odd discount seems too much (to me). The exec have not bought on market
recently, so todays announced deal is just too convenient and easy in my view sort of like "let them eat cake".

.535

1		30/11/22	Dr Liz Dallimore	Issued	2,000,000
2	30/11/22	Dr Liz Dallimore	Issued	2,000,000	$0.535	$1,070,000	Issued under employee share plan
,070,000	Issued under employee share plan
3	14/06/22	Dr Liz Dallimore	Buy	+10,916	$0.400	$4,366	On-market trade
4	14/06/22	Mr Geoffrey (Geoff) Richard Pocock	Buy	+27,000	$0.410	$11,070	On-market trade
5	10/06/22	Dr Liz Dallimore	Buy	+39,084	$0.400	$15,633	On-market trade
6	10/06/22	Mr Geoffrey (Geoff) Richard Pocock	Buy	+32,690	$0.414	$13,532	On-market trade
7	25/02/22	Mr Terrence (Terry) Charles Budge	Buy	+32,520	$0.639	$20,786	On-market trade

I'm generally relaxed about CRs when they seem reasonable and I've been watching the shorts on AGN just in case ... but this one seems too cheap to me ... unless ... there is more risk there than we know.

@distantcomment just click my profile and look back about 4 or 5 posts.